Angiotensin-converting enzyme inhibitory assay

CR Cecilia Mónica Rodríguez-García
JR Jorge Carlos Ruiz-Ruiz
LP Leticia Peraza-Echeverría
SP Sergio Rubén Peraza-Sánchez
LT Luis Wiliunfo Torres-Tapia
DP Daisy Pérez-Brito
RT Raúl Tapia-Tussell
FH Francisco Gilberto Herrera-Chalé
MS Maira Rubí Segura-Campos
AQ Andrés Quijano-Ramayo
JR Jesús Manuel Ramón-Sierra
EO Elizabeth Ortiz-Vázquez
request Request a Protocol
ask Ask a question
Favorite

Inhibitory activity of aqueous extracts was analyzed following a method by Hayakari et al. [22] https://dx.doi.org/10.17504/protocols.io.tb4eiqw. Hippuryl-L-histidyl-L-leucine (HHL) (Sigma) was hydrolyzed by ACE to yield hippuric acid and histidyl-leucine. This method relies on the colorimetric reaction of hippuric acid with 2, 4, 6-trichloro-s-triazine (TT) (Sigma). The tests were performed in triplicate and antihypertensive activity was quantified by a regression analysis of ACE inhibitory activity (%) versus phenolic compounds concentration in aqueous extract and defined as an IC50 value, that is, the concentration of phenolic compounds required to produce 50% ACE inhibition under the conditions described. For angiotensin-converting enzyme inhibitory assay, lisinopril (antihypertensive drug) was used as control.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A